Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
SERB Pays $800m For Boston Scientific Specialty Pharma Business
Device Maker Acquired The Drugs In $4.2bn BTG Buy Last Year
Dec 02 2020
•
By
Reed Miller
Boston Scientific's sale of BTG Specialty Pharmaceuticals was anticipated when it bought BTG plc for $4.2bn • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business